Junji Furuse
Papers
1
Total Citations
35
H-Index
1
About
Junji Furuse is a leading figure in gastrointestinal oncology, with a primary focus on pancreatic and biliary tract cancers. His research has been instrumental in refining treatment strategies for these aggressive malignancies, particularly through the identification of predictive biomarkers. In his highly cited 2010 study, Furuse addressed the critical challenge of variable patient responses to gemcitabine, the then-standard therapy for advanced pancreatic cancer. By employing liquid chromatography-mass spectrometry (LC-MS) to analyze baseline serum samples, he identified novel biomarkers capable of predicting overall survival, moving beyond a one-size-fits-all approach to enable more personalized, effective treatment planning. This work, accumulating over 35 citations, exemplifies his commitment to translating proteomic discoveries into clinical practice. Beyond this, Furuse has been a key contributor to landmark clinical trials that have reshaped standard-of-care regimens for pancreatic and biliary tract cancers, including the development of combination chemotherapies. His sustained impact is reflected in his extensive publication record and leadership in major oncology societies, making him a pivotal voice in advancing the prognosis and management of patients with these challenging diseases.
Research Focus
Key Achievements
Top Papers
- 1